Detection of differentially culturable tubercle bacteria in sputum using mycobacterial culture filtrates.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 03 2021
Historique:
received: 05 11 2020
accepted: 01 03 2021
entrez: 23 3 2021
pubmed: 24 3 2021
medline: 16 10 2021
Statut: epublish

Résumé

Rapid detection of tuberculosis (TB) infection is paramount to curb further transmission. The gold standard for this remains mycobacterial culture, however emerging evidence confirms the presence of differentially culturable tubercle bacteria (DCTB) in clinical specimens. These bacteria do not grow under standard culture conditions and require the presence of culture filtrate (CF), from axenic cultures of Mycobacterium tuberculosis (Mtb), to emerge. It has been hypothesized that molecules such as resuscitation promoting factors (Rpfs), fatty acids and cyclic-AMP (cAMP) present in CF are responsible for the growth stimulatory activity. Herein, we tested the ability of CF from the non-pathogenic bacterium Mycobacterium smegmatis (Msm) to stimulate the growth of DCTB, as this organism provides a more tractable source of CF. We also interrogated the role of Mtb Rpfs in stimulation of DCTB by creating recombinant strains of Msm that express Mtb rpf genes in various combinations. CF derived from this panel of strains was tested on sputum from individuals with drug susceptible TB prior to treatment. CF from wild type Msm did not enable detection of DCTB in a manner akin to Mtb CF preparations and whilst the addition of RpfAB

Identifiants

pubmed: 33753820
doi: 10.1038/s41598-021-86054-z
pii: 10.1038/s41598-021-86054-z
pmc: PMC7985135
doi:

Substances chimiques

Bacterial Proteins 0
Cytokines 0
resuscitation-promoting factor, bacteria 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6493

Références

Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):E4832-E4840
pubmed: 28559332
Infect Immun. 2005 May;73(5):3038-43
pubmed: 15845511
Front Microbiol. 2019 Oct 23;10:2381
pubmed: 31749768
FEBS J. 2015 Jul;282(13):2500-11
pubmed: 25846449
Am J Respir Crit Care Med. 2016 Dec 15;194(12):1448-1451
pubmed: 27976945
Mol Microbiol. 2008 Feb;67(3):672-84
pubmed: 18186793
PLoS One. 2013 Dec 23;8(12):e82914
pubmed: 24376605
Am J Respir Crit Care Med. 2010 Jan 15;181(2):174-80
pubmed: 19875686
Microbiology (Reading). 2007 Aug;153(Pt 8):2711-2723
pubmed: 17660435
PLoS Med. 2008 Apr 1;5(4):e75
pubmed: 18384229
J Bacteriol. 1999 Jan;181(1):270-83
pubmed: 9864340
Microbiology (Reading). 2004 Jun;150(Pt 6):1687-1697
pubmed: 15184555
BMC Microbiol. 2014 Mar 24;14:75
pubmed: 24661741
Am J Respir Crit Care Med. 2016 Dec 15;194(12):1532-1540
pubmed: 27387272
Infect Immun. 2006 May;74(5):2985-95
pubmed: 16622237
Antonie Van Leeuwenhoek. 2013 Jan;103(1):37-46
pubmed: 22864992
Mol Microbiol. 2002 Nov;46(3):611-21
pubmed: 12410820
Lancet. 2016 Mar 19;387(10024):1211-26
pubmed: 26377143
Infect Immun. 2008 Sep;76(9):4269-81
pubmed: 18591237
Mol Microbiol. 1990 Nov;4(11):1911-9
pubmed: 2082148
Appl Environ Microbiol. 2018 Aug 17;84(17):
pubmed: 29915116
FEMS Immunol Med Microbiol. 2010 Feb;58(1):39-50
pubmed: 19799629
Mol Microbiol. 2002 Nov;46(3):623-35
pubmed: 12410821

Auteurs

Bhavna G Gordhan (BG)

Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, P. O. Box 1038, Johannesburg, 2000, South Africa.

Julian S Peters (JS)

Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, P. O. Box 1038, Johannesburg, 2000, South Africa.

Amanda McIvor (A)

Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, P. O. Box 1038, Johannesburg, 2000, South Africa.

Edith E Machowski (EE)

Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, P. O. Box 1038, Johannesburg, 2000, South Africa.

Christopher Ealand (C)

Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, P. O. Box 1038, Johannesburg, 2000, South Africa.

Ziyaad Waja (Z)

Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Neil Martinson (N)

Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, P. O. Box 1038, Johannesburg, 2000, South Africa.
Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Center for Tuberculosis Research, Johns Hopkins University, Baltimore, MD, USA.

Bavesh D Kana (BD)

Department of Science and Technology/National Research Foundation Centre of Excellence for Biomedical TB Research, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand and the National Health Laboratory Service, P. O. Box 1038, Johannesburg, 2000, South Africa. bavesh.kana@wits.ac.za.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH